95 related articles for article (PubMed ID: 6800050)
21. Immunological studies in typhoid fever. I. Immunoglobulins, C3, antibodies, rheumatoid factor and circulating immune complexes in patients with typhoid fever.
Rajagopalan P; Kumar R; Malaviya AN
Clin Exp Immunol; 1981 Apr; 44(1):68-73. PubMed ID: 6973435
[TBL] [Abstract][Full Text] [Related]
22. [Circulating immune complexes in different developmental stages of Chagas' disease].
Martín UO; Afchain D; de Marteleur A; Ledesma O; Caprón A
Medicina (B Aires); 1987; 47(2):159-62. PubMed ID: 3121979
[No Abstract] [Full Text] [Related]
23. Regimens of factor VIII administration--continuous infusion vs. bolus.
Berntorp E
Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of circulating immune complexes in various forms of systemic small vessel vasculitis.
Kauffmann RH; Valentijn RM
Neth J Med; 1982; 25(7):193-201. PubMed ID: 7144989
[No Abstract] [Full Text] [Related]
25. Enhanced communication between care professionals and patients with hemophilia by using a web enabled electronic logbook.
Roosendaal G; Drenth ER; Poerschke M; Verkerk EC; Van den Berg HM; Metselaar M
Stud Health Technol Inform; 2004; 103():191-4. PubMed ID: 15747920
[TBL] [Abstract][Full Text] [Related]
26. [Circulating immune complexes in pyelo- and glomerulonephritis patients].
Chebotareva VD; Vagdasarova IV; Maĭdannik VG
Vrach Delo; 1984 Aug; (8):66-9. PubMed ID: 6506618
[No Abstract] [Full Text] [Related]
27. [Circulating immune complexes in children with synpneumonic and metapneumonic pleurisy].
Tatochenko VK; Panasiuk NL; Katosova LK
Probl Tuberk; 1985; (7):52-5. PubMed ID: 4048138
[No Abstract] [Full Text] [Related]
28. [Hepatitis A and hemophilia in Aragon, Spain].
García Erce JA; Solano Bernad VM; Ferrer Torres J; Lucía Cuesta JF
Sangre (Barc); 1997 Jun; 42(3):252-3. PubMed ID: 9381275
[No Abstract] [Full Text] [Related]
29. Dose and response in haemophilia--optimization of factor replacement therapy.
Srivastava A
Br J Haematol; 2004 Oct; 127(1):12-25. PubMed ID: 15384973
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
Monahan PE; Aledort LM;
Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
[TBL] [Abstract][Full Text] [Related]
31. [Risk of posttransfusion hepatitis in hemophilia patients].
Margolina AN; Somova AV; Golosova TV; Pliushch OP; Andreev IuN
Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):46-8. PubMed ID: 7367412
[No Abstract] [Full Text] [Related]
32. The prevalence of Australia antigen and antibody in haemophilia.
Essien EM; Smith JA; Francis TI
Acta Haematol; 1973; 50(5):293-8. PubMed ID: 4202633
[No Abstract] [Full Text] [Related]
33. [Appearance of anti-c (anti-hr') antibodies in combination with anti-leukocyte antibodies in patient with hemophilia].
Burlachenko IS; Zhukova NA
Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):49-51. PubMed ID: 4981802
[No Abstract] [Full Text] [Related]
34. Treatment of hemophilia in developing countries: a journey of a thousand miles.
Gruppo RA
Pediatr Blood Cancer; 2010 Mar; 54(3):348-9. PubMed ID: 20049926
[No Abstract] [Full Text] [Related]
35. The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics.
Balkan C; Kavakli K; Kutukculer N; Aksu G; Yilmaz D; Aydinok Y
Haemophilia; 2005 Jul; 11(4):366-70. PubMed ID: 16011589
[TBL] [Abstract][Full Text] [Related]
36. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates.
Sharp CP; Lail A; Donfield S; Gomperts ED; Simmonds P
Transfusion; 2012 Jul; 52(7):1482-9. PubMed ID: 22043925
[TBL] [Abstract][Full Text] [Related]
37. [Circulating immune complexes in immune hemocytopenias].
Loginskiĭ VE; Vygovskaia IaI; Zakharchuk LS
Sov Med; 1984; (12):12-6. PubMed ID: 6543030
[No Abstract] [Full Text] [Related]
38. [Continuous infusion of coagulant factor concentrates and its pharmacokinetics in patients with hemophilics having low titer inhibitor].
Fujii T; Takata N; Kimura A
Rinsho Ketsueki; 2007 Apr; 48(4):321-5. PubMed ID: 17515124
[TBL] [Abstract][Full Text] [Related]
39. Antigen-antibody complexes in hemophilia.
Hilgartner M
Scand J Haematol Suppl; 1984; 40():335-9. PubMed ID: 6236551
[No Abstract] [Full Text] [Related]
40. [Circulating immune complexes in hepatitis A].
Boroń-Kaczmarska A; Alvermann B; Püschel J; Spies K
Przegl Epidemiol; 1981; 35(2):267-70. PubMed ID: 7313137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
